Ten63, spun out of Duke University in 2019, announced it had secured strategic investments led by the Chugai Venture Fund and the Gates Foundation. The investments bring the company’s total funding to ...

“With the brepocitinib CS program now moving into Phase 3 alongside the dermatomyositis and non-infectious uveitis programs, Priovant continues to advance our goal of developing brepocitinib as a ...

Durham-based Precision BioSciences, a gene-editing company, has received regulatory clearance to begin a clinical study of its potential treatment for Duchenne muscular dystrophy (DMD), a rare ...

Durham Tech Connects is a career networking event for professionals, students, and alumni from life sciences and related fields. This event is hosted by Durham Tech's Life Sciences Program.

A trusted leader who offered a steady hand and strong leadership on an interim basis in an ever-changing research environment, Sharon Paynter, Ph.D., has been named Senior Vice Provost for Research ...

If 2025 had a theme for the Charlotte region's life sciences ecosystem, it was this: years of planning finally meeting their moment. From landmark facility openings to record-breaking workforce ...

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body.

The Greater Raleigh Chamber and Wake County Economic Development joined forces to host a dynamic event that explores the evolving life sciences landscape in Wake County and the Research Triangle ...